About
Kristen Harrington-Smith serves as ADC Therapeutics' Chief Commercial Officer, which she joined in November 2022, and brings more than 20 years of experience in the pharmaceutical industry. She was most recently Chief Commercial Officer at ImmunoGen, and previously held roles at Novartis including U.S. Commercial Head of Hematology, where she was responsible for the Kymriah CAR-T launch. She holds a B.A. from Williams College and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.
Roles
ADC Therapeutics SA
Chief Commercial Officer · Current role
November 2022–present
ADC Therapeutics
Chief Commercial Officer
November 2022 - present
ImmunoGen
Chief Commercial Officer
—
Novartis
U.S. Commercial Head of Hematology
—
External Roles
eFFECTOR Therapeutics
Director
—
eFFECTOR Therapeutics
Board member
—
Also at ADC Therapeutics SA
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.